These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals. Liu SH; Shen CC; Yi YC; Tsai JJ; Wang CC; Chueh JT; Lin KL; Lee TC; Pan HC; Sheu ML Br J Pharmacol; 2010 Aug; 160(8):1963-72. PubMed ID: 20649594 [TBL] [Abstract][Full Text] [Related]
7. Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice. Yagi Y; Fushida S; Harada S; Tsukada T; Kinoshita J; Oyama K; Fujita H; Ninomiya I; Fujimura T; Kayahara M; Kinuya S; Yashiro M; Hirakawa K; Ohta T Cancer Chemother Pharmacol; 2010 Sep; 66(4):745-53. PubMed ID: 20033809 [TBL] [Abstract][Full Text] [Related]
8. Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer. Bae WK; Park MS; Lee JH; Hwang JE; Shim HJ; Cho SH; Kim DE; Ko HM; Cho CS; Park IK; Chung IJ Biomaterials; 2013 Jan; 34(4):1433-41. PubMed ID: 23174142 [TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitor SU6668 inhibits peritoneal dissemination of gastric cancer via suppression of tumor angiogenesis. Tokuyama J; Kubota T; Saikawa Y; Yoshida M; Furukawa T; Otani Y; Kumai K; Kitajima M Anticancer Res; 2005; 25(1A):17-22. PubMed ID: 15816514 [TBL] [Abstract][Full Text] [Related]
10. [Intraoperative and postoperative intra-peritoneal administration of peptide PIII inhibits peritoneal metastasis of gastric cancer]. Bai FH; Yang L; Ji Q; Zhang YQ; Liu ZX; Wang ZZ; Yan L; Wang JB; Jin HF; Li TT Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3260-3. PubMed ID: 17313805 [TBL] [Abstract][Full Text] [Related]
11. Elevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in mice. Matsuoka T; Adair JE; Lih FB; Hsi LC; Rubino M; Eling TE; Tomer KB; Yashiro M; Hirakawa K; Olden K; Roberts JD Br J Cancer; 2010 Oct; 103(8):1182-91. PubMed ID: 20842125 [TBL] [Abstract][Full Text] [Related]
12. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. Kuniyasu H; Oue N; Wakikawa A; Shigeishi H; Matsutani N; Kuraoka K; Ito R; Yokozaki H; Yasui W J Pathol; 2002 Feb; 196(2):163-70. PubMed ID: 11793367 [TBL] [Abstract][Full Text] [Related]
13. Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo. Zhang L; Kim S; Ding W; Tong Y; Zhang X; Pan M; Chen S Drug Des Devel Ther; 2015; 9():5579-90. PubMed ID: 26487802 [TBL] [Abstract][Full Text] [Related]
14. Pioglitazone, a ligand for peroxisome proliferator-activated receptor-gamma acts as an inhibitor of colon cancer liver metastasis. Takano S; Kubota T; Nishibori H; Hasegawa H; Ishii Y; Nitori N; Ochiai H; Okabayashi K; Kitagawa Y; Watanabe M; Kitajima M Anticancer Res; 2008; 28(6A):3593-9. PubMed ID: 19189639 [TBL] [Abstract][Full Text] [Related]
15. Potent antitumor effect of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine on peritoneal dissemination models of gastrointestinal cancers. Miura S; Endo Y; Yoshimura Y; Endo M; Yonemura Y; Sasaki T Oncol Rep; 2002; 9(6):1319-22. PubMed ID: 12375041 [TBL] [Abstract][Full Text] [Related]
16. The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38. LaBonte MJ; Manegold PC; Wilson PM; Fazzone W; Louie SG; Lenz HJ; Ladner RD Int J Cancer; 2009 Dec; 125(12):2957-69. PubMed ID: 19536776 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers. Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer. Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429 [TBL] [Abstract][Full Text] [Related]
19. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer. Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691 [TBL] [Abstract][Full Text] [Related]
20. 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ). Tan BS; Kang O; Mai CW; Tiong KH; Khoo AS; Pichika MR; Bradshaw TD; Leong CO Cancer Lett; 2013 Aug; 336(1):127-39. PubMed ID: 23612072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]